Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Octaplex vs FFP for Urgent Surgery in VKA Patients
NCT00618098Phase 3Completed
- Sponsor
- Octapharma
- Start
- May 2008
- Primary completion
- Mar 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of balfaxar in Anticoagulant-induced coagulopathy, sponsored by Octapharma. Started May 2008; status: completed.
02
Drugs
balfaxar
03
Conditions
Anticoagulant-induced coagulopathy
Beyond the preview
Go deeper on NCT00618098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00618098.